DVx Inc. Reports Non-Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Non-Consolidated Earnings Guidance for the First Half and Full Year of Fiscal 2018; Announces Year-End Dividend for the Year Ended March 31, 2017, Payable on June 29, 2017; Provides Year-End Dividend Guidance for the Year Ending March 31, 2018
May 14, 2017
Share
DVx Inc. reported non-consolidated earnings results for the year ended March 31, 2017. For the year, the company's net sales were ¥35,266.8 million against ¥31,372.1 million last year. Operating profit was ¥1,524.97 million against ¥1,492.44 million last year. Ordinary profit was ¥1,491.4 million against ¥1,460.5 million last year. Profit before income taxes was ¥1,490.5 million compared with ¥1,919.2 million a year ago. Profit was ¥1,025.99 million or ¥90.98 per share against ¥1,289.7 million or ¥114.36 per share last year. Cash from operating activities was ¥1,152.2 million against ¥1,311.9 million last year. Purchase of property, plant and equipment was ¥126.6 million against ¥144.9 million last year. Purchase of intangible assets was ¥13.9 million against ¥29.7 million last year.
For the half year ending September 30, 2017, the company expects net sales of ¥18,442 million, operating profit of ¥565 million, ordinary profit of ¥565 million, and profit of ¥379 million or ¥33.61 per share.
For the year ending March 31, 2018, the company expects net sales of ¥38,377 million, operating profit of ¥1,171 million, ordinary profit of ¥1,171 million, and profit of ¥783 million or ¥69.50 per share.
The company announced year-end dividend of ¥23.00 per share for the year ended March 31, 2017. The company paid year-end dividend of ¥23.00 per share for the same period last year. The dividend will be payable on June 29, 2017. The company also announced total dividend of ¥23.00 per share for the year ended March 31, 2017.
The company forecasts year-end dividend of ¥23.00 per share for the year ending March 31, 2018 against ¥23.00 per share for the same period a year ago. The company also forecasts total dividend of ¥23.00 per share for the year ending March 31, 2018.
DVx Inc. is a Japan-based company mainly engaged in the sale of medical equipment for circulatory system diseases. The Company operates in two business segments. The Arrhythmia segment mainly sells cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), electrode catheters and ablation catheters. The Ischemia segment is engaged in the import and sale of automated contrast medium injectors under the name ACIST, excimer laser angioplasty systems, as well as sale of coronary artery stent products as agency business. The others business is engaged in the sale of neurosurgical products, general surgery related products, gastrointestinal related products, radiation protection supplies, among others.
DVx Inc. Reports Non-Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Non-Consolidated Earnings Guidance for the First Half and Full Year of Fiscal 2018; Announces Year-End Dividend for the Year Ended March 31, 2017, Payable on June 29, 2017; Provides Year-End Dividend Guidance for the Year Ending March 31, 2018